🇺🇸 iNO in United States

22 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 22

Most-reported reactions

1. Leukopenia — 3 reports (13.64%)
2. Respiratory Failure — 3 reports (13.64%)
3. Blindness — 2 reports (9.09%)
4. Cardiac Arrest — 2 reports (9.09%)
5. Completed Suicide — 2 reports (9.09%)
6. Diarrhoea — 2 reports (9.09%)
7. Gamma-Glutamyltransferase Increased — 2 reports (9.09%)
8. General Physical Health Deterioration — 2 reports (9.09%)
9. Insomnia — 2 reports (9.09%)
10. Platelet Count Decreased — 2 reports (9.09%)

Source database →

Frequently asked questions

Is iNO approved in United States?

iNO does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for iNO in United States?

Wake Forest University Health Sciences is the originator. The local marketing authorisation holder may differ — check the official source linked above.